OS Therapies Revenue

Biotechnology Research • Manhattan, New York, United States • 11-20 Employees

OS Therapies revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	$18,300,000

Key Contacts at OS Therapies

Olivier Jarry

Non Executive Director

Paul Romness

Ceo

Company overview

Headquarters	101 6th Avenue, 3rd Floor, JLABS, New York, NY 10013, US
Phone number	+14102977793
Website	ostherapies.com
NAICS	541714
SIC	873
Keywords	Lung Cancer, Breast Cancer, Oncology, Pediatric Cancer, Ovarian Cancer, Solid Tumors, Osteosarcoma
Founded	2018
Employees	11-20
Socials

OS Therapies Email Formats

OS Therapies uses 2 email formats. The most common is {2char} (e.g., {2char}@ostherapies.com), used 50% of the time.

Format	Example	Percentage
{2char}	{2char}@ostherapies.com	50%
{first initial}{last name}	jdoe@ostherapies.com	50%

About OS Therapies

OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors. OST-HER2 is completing a PhIIb clinical trial in 4Q2024 with significantly improved Event Free Survival (EFS), and early Overall Survival (OS). OST-tADC is a ph-sensitive novel pre-clinical Drug Conjugate that uses proprietary (IP) Silicon to cover and link the multiple payloads until they are delivered to the acidic cancer environment, dissolving the Silicon - delivering and activating the payloads.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

OS Therapies has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore OS Therapies's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2021-08-16	12	$1,000,000
2025-01-24	14	$6,000,000
2025-02-14	14	$7,100,000
2025-08-14	14	$4,200,000

Funding Insights

$18,300,000

Total funding amount

$4,200,000

Most recent funding amount

Number of funding rounds

OS Therapies Tech Stack

Discover the technologies and tools that power OS Therapies's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

CivicTheme

UI frameworks

Oxygen

Page builders

Google Maps

Maps

Cloudflare

CDN

Genesis theme

WordPress themes

jQuery

JavaScript libraries

Motion.page

WordPress plugins

PHP

Programming languages

WordPress

Blogs

Automatic.css

UI frameworks

RankMath SEO

SEO

Frequently asked questions

OS Therapies is located in Manhattan, New York, US.

You can reach OS Therapies at +14102977793.

OS Therapies generates an estimated annual revenue of $941,105. This revenue figure reflects the company's market position and business performance in its industry.

OS Therapies has an estimated valuation of $3,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

OS Therapies was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

OS Therapies has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

OS Therapies has raised a total of $18,300,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at OS Therapies

Olivier Jarry

Non Executive Director

Paul Romness

Ceo

4.8

40,000 users